Fulgent Genetics Inc.

85.41+0.1700+0.20%Vol 721.64K1Y Perf 709.00%
Apr 9th, 2021 16:00 DELAYED
BID84.50 ASK86.09
Open84.59 Previous Close85.24
Pre-Market- After-Market-
 - -  - -%
Target Price
96.67 
Analyst Rating
Strong Buy 1.00
Potential %
13.18 
Finscreener Ranking
★★★★★     65.02
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★★★     65.49
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★★     83.62
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Market Cap2.48B 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
41.83 
Earnings Date
3rd May 2021

Today's Price Range

82.4186.67

52W Range

10.27189.89

5 Year PE Ratio Range

-670.00-17.70

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-14.97%
1 Month
-12.13%
3 Months
34.84%
6 Months
94.11%
1 Year
709.00%
3 Years
2 062.28%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
FLGT85.410.17000.20
AAPL132.992.63002.02
GOOG2 285.8820.44000.90
MSFT255.852.60001.03
XOM55.87-0.1300-0.23
WFC40.500.47001.17
JNJ161.25-1.7200-1.06
FB312.46-0.5600-0.18
GE13.600.15001.12
JPM156.281.16000.75
Financial StrengthValueIndustryS&P 500US Markets
3.90
4.00
0.00
0.03
-
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
78.70
47.20
49.00
1.60
52.40
RevenueValueIndustryS&P 500US Markets
413.96M
14.28
168.32
73.33
Earnings HistoryEstimateReportedSurprise %
Q04 20204.366.1240.37
Q03 20200.391.95400.00
Q02 20200.010.171.60K
Q01 2020-0.07-0.08-14.29
Q04 20190.030.00-100.00
Q03 20190.010.09800.00
Q02 2019-0.040.02150.00
Q01 2019-0.06-0.09-50.00
Earnings Per EndEstimateRevision %Trend
3/2021 QR5.95245.93Positive
6/2021 QR2.7578.57Positive
12/2021 FY12.22126.30Positive
12/2022 FY4.19--
Next Report Date3rd May 2021
Estimated EPS Next Report5.95
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume721.64K
Shares Outstanding28.99M
Trades Count12.71K
Dollar Volume123.87M
Avg. Volume2.08M
Avg. Weekly Volume1.25M
Avg. Monthly Volume1.62M
Avg. Quarterly Volume1.98M

Fulgent Genetics Inc. (NASDAQ: FLGT) stock closed at 85.41 per share at the end of the most recent trading day (a 0.2% change compared to the prior day closing price) with a volume of 724.39K shares and market capitalization of 2.48B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 139 people. Fulgent Genetics Inc. CEO is Ming Hsieh.

The one-year performance of Fulgent Genetics Inc. stock is 709%, while year-to-date (YTD) performance is 63.93%. FLGT stock has a five-year performance of %. Its 52-week range is between 10.27 and 189.89, which gives FLGT stock a 52-week price range ratio of 41.83%

Fulgent Genetics Inc. currently has a PE ratio of 10.90, a price-to-book (PB) ratio of 4.92, a price-to-sale (PS) ratio of 7.03, a price to cashflow ratio of 16.50, a PEG ratio of 2.32, a ROA of 53.77%, a ROC of 37.87% and a ROE of 64.99%. The company’s profit margin is 52.40%, its EBITDA margin is 49.00%, and its revenue ttm is $413.96 Million , which makes it $14.28 revenue per share.

Of the last four earnings reports from Fulgent Genetics Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $5.95 for the next earnings report. Fulgent Genetics Inc.’s next earnings report date is 03rd May 2021.

The consensus rating of Wall Street analysts for Fulgent Genetics Inc. is Strong Buy (1), with a target price of $96.67, which is +13.18% compared to the current price. The earnings rating for Fulgent Genetics Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Fulgent Genetics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Fulgent Genetics Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 19.17, ATR14 : 17.44, CCI20 : -44.60, Chaikin Money Flow : -0.16, MACD : -3.42, Money Flow Index : 40.91, ROC : 3.93, RSI : 50.59, STOCH (14,3) : 47.55, STOCH RSI : 1.00, UO : 42.20, Williams %R : -52.45), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Fulgent Genetics Inc. in the last 12-months were: Han Lin Gao (Sold 1 609 shares of value $67 452 ), Jian Xie (Sold 83 519 shares of value $7 280 278 ), John C. Bolger (Option Excercise at a value of $103 794), John C. Bolger (Sold 32 825 shares of value $1 118 270 ), Paul Kim (Sold 301 646 shares of value $13 470 973 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to a disease and enhanced disease treatment and prognosis.

CEO: Ming Hsieh

Telephone: +1 626 350-0537

Address: 4978 Santa Anita Avenue, Temple City 91780, CA, US

Number of employees: 139

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

56%44%

Bearish Bullish

53%47%

Bearish Bullish

53%47%

News

Stocktwits